Devi, N. S. et al. Overview of antimicrobial resistance and mechanisms: The relative status of the past and current. Microbe 3, 100083 (2024).
Smith, W. P. J., Wucher, B. R., Nadell, C. D. & Foster, K. R. Bacterial defences: mechanisms, evolution and antimicrobial resistance. Nat. Rev. Microbiol. 21, 519–534 (2023).
Darby, E. M. et al. Molecular mechanisms of antibiotic resistance revisited. Nat. Rev. Microbiol. 21, 280–295 (2023).
Rosas, N. C. & Lithgow, T. Targeting bacterial outer-membrane remodelling to impact antimicrobial drug resistance. Trends Microbiol. 30, 544–552 (2022).
Mansilla, M. C. & Mendoza, D. D. Regulation of Membrane Lipid Homeostasis in Bacteria upon Temperature Change. In Biogenesis of Fatty Acids, Lipids and Membranes. Handbook of Hydrocarbon and Lipid Microbiology. (eds Geiger, O.) pp.1–13, (Springer, Cham, 2016).
Chwastek, G. et al. Principles of Membrane Adaptation Revealed through Environmentally Induced Bacterial Lipidome Remodeling. Cell Rep. 32, 108165 (2020).
Agmon, E. & Stockwell, B. R. Lipid homeostasis and regulated cell death. Curr. Opin. Chem. Biol. 39, 83–89 (2017).
Winnikoff, J. R. et al. Homeocurvature adaptation of phospholipids to pressure in deep-sea invertebrates. Science. (N. Y., N. Y.) 384, 1482–1488 (2024).
Wood, J. M. Bacterial responses to osmotic challenges. J. Gen. Physiol. 145, 381–388 (2015).
Malanovic, N. & Lohner, K. Antimicrobial Peptides Targeting Gram-Positive Bacteria. Pharmaceuticals (Basel, Switzerland) 9, 59 (2016).
Malanovic, N. & Lohner, K. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides. Biochimica et. biophysica acta. 1858, 936–946 (2016).
Khondker, A. & Rheinstädter, M. C. How do bacterial membranes resist polymyxin antibiotics? Commun. Biol. 3, 77 (2020).
Global burden of bacterial antimicrobial resistance in 2019 a systematic analysis. Lancet (Lond., Engl.) 399, 629–655 (2022).
Hoenigl, M. et al. COVID-19-associated fungal infections. Nat. Microbiol. 7, 1127–1140 (2022).
Shafran, N. et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci. Rep. 11, 12703 (2021).
Galeano Niño, J. L. et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature 611, 810–817 (2022).
Malanovic, N. & Vejzovic, D. Novel insights at the crossroads of antibiotic use and cancer risk. Cell stress 7, 46–49 (2023).
Narunsky-Haziza, L. et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell 185, 3789–3806.e17 (2022).
Sinha, G. Tumors can teem with microbes. But what are they doing there? Sci. (N. Y., N. Y.) 378, 693–694 (2022).
Malanovic, N. et al. Disruption of the Cytoplasmic Membrane Structure and Barrier Function Underlies the Potent Antiseptic Activity of Octenidine in Gram-Positive Bacteria. Appl. Environ. Microbiol. 88, 10.e0018022 (2022).
Malanovic, N., Ön, A., Pabst, G., Zellner, A. & Lohner, K. Octenidine: Novel insights into the detailed killing mechanism of Gram-negative bacteria at a cellular and molecular level. Int. J. antimicrobial agents 56, 106146 (2020).
Vejzovic, D., Iftic, A., Ön, A., Semeraro, E. F. & Malanovic, N. Octenidine’s Efficacy: A Matter of Interpretation or the Influence of Experimental Setups? Antibiotics (Basel, Switzerland) 11, 1665 (2022).
Dhoonmoon, L. & Malanovic, N. Enhancing patient outcomes: the role of octenidine-based irrigation solutions in managing sore and irritated peristomal skin. J. wound care 34, S4–S11 (2025).
Bock, L. J. et al. Pseudomonas aeruginosa adapts to octenidine via a combination of efflux and membrane remodelling. Commun. Biol. 4, 1058 (2021).
Lescat, M., Magnan, M., Kenmoe, S., Nordmann, P. & Poirel, L. Co-Lateral Effect of Octenidine, Chlorhexidine and Colistin Selective Pressures on Four Enterobacterial Species: A Comparative Genomic Analysis. Antibiotics (Basel, Switzerland) 11, 50 (2021).
Dijksteel, G. S., Ulrich, M. M. W., Middelkoop, E. & Boekema, B. K. H. L. Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs). Front. Microbiol. 12, 616979 (2021).
Ridyard, K. E. & Overhage, J. The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent. Antibiotics (Basel, Switzerland) 10, 650 (2021).
de Breij, A. et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci. Transl. Med. 10, 423 (2018).
Malanovic, N., Marx, L., Blondelle, S. E., Pabst, G. & Semeraro, E. F. Experimental concepts for linking the biological activities of antimicrobial peptides to their molecular modes of action. Biochimica et. biophysica acta Biomembranes 1862, 183275 (2020).
Piller, P. et al. Membrane Activity of LL-37 Derived Antimicrobial Peptides against Enterococcus hirae: Superiority of SAAP-148 over OP-145. Biomolecules 12, 523 (2022).
Ön, A. et al. Bactericidal Activity to Escherichia coli: Different Modes of Action of Two 24-Mer Peptides SAAP-148 and OP-145, Both Derived from Human Cathelicidine LL-37. Antibiotics (Basel, Switzerland) 12, 1163 (2023).
Vejzovic, D. et al. Where Electrostatics Matter: Bacterial Surface Neutralization and Membrane Disruption by Antimicrobial Peptides SAAP-148 and OP-145. Biomolecules 12, 1252 (2022).
Wenzel, M. et al. Small cationic antimicrobial peptides delocalize peripheral membrane proteins. Proc. Natl. Acad. Sci. USA 111, E1409–E1418 (2014).
Butler, M. S., Henderson, I. R., Capon, R. J. & Blaskovich, M. A. T. Antibiotics in the clinical pipeline as of December 2022. J. Antibiotics 76, 431–473 (2023).
Zhang, H.-Q., Sun, C., Xu, N. & Liu, W. The current landscape of the antimicrobial peptide melittin and its therapeutic potential. Front. Immunol. 15, 1326033 (2024).
Kahlenberg, J. M. & Kaplan, M. J. Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease. J. Immunol. (Baltim., Md.: 1950) 191, 4895–4901 (2013).
Yang, L., Harroun, T. A., Weiss, T. M., Ding, L. & Huang, H. W. Barrel-stave model or toroidal model? A case study on melittin pores. Biophysical J. 81, 1475–1485 (2001).
Oren, Z., Lerman, J. C., Gudmundsson, G. H., Agerberth, B. & Shai, Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochemical J. 341, 501–513 (1999).
Lee, C.-C., Sun, Y., Qian, S. & Huang, H. W. Transmembrane pores formed by human antimicrobial peptide LL-37. Biophysical J. 100, 1688–1696 (2011).
Yang, Z., Choi, H. & Weisshaar, J. C. Melittin-Induced Permeabilization, Re-sealing, and Re-permeabilization of E. coli Membranes. Biophysical J. 114, 368–379 (2018).
Sancho-Vaello, E. et al. The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics. Sci. Rep. 10, 17356 (2020).
Majewska, M., Zamlynny, V., Pieta, I. S., Nowakowski, R. & Pieta, P. Interaction of LL-37 human cathelicidin peptide with a model microbial-like lipid membrane. Bioelectrochemistry (Amst., Neth.) 141, 107842 (2021).
Hong, J. et al. How Melittin Inserts into Cell Membrane: Conformational Changes, Inter-Peptide Cooperation, and Disturbance on the Membrane. Molecules (Basel, Switzerland) 24, 1775 (2019).
Porcelli, F. et al. NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry 47, 5565–5572 (2008).
Sevcsik, E., Pabst, G., Jilek, A. & Lohner, K. How lipids influence the mode of action of membrane-active peptides. Biochimica et. biophysica acta. 1768, 2586–2595 (2007).
Sevcsik, E. et al. Interaction of LL-37 with model membrane systems of different complexity: influence of the lipid matrix. Biophysical J. 94, 4688–4699 (2008).
van den Bogaart, G., Mika, J. T., Krasnikov, V. & Poolman, B. The lipid dependence of melittin action investigated by dual-color fluorescence burst analysis. Biophysical J. 93, 154–163 (2007).
Sochacki, K. A., Barns, K. J., Bucki, R. & Weisshaar, J. C. Real-time attack on single Escherichia coli cells by the human antimicrobial peptide LL-37. Proc. Natl. Acad. Sci. USA 108, E77–E81 (2011).
White, J. K. et al. A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens. Cell. Mol. life Sci. : CMLS 79, 411 (2022).
Strömstedt, A. A., Wessman, P., Ringstad, L., Edwards, K. & Malmsten, M. Effect of lipid headgroup composition on the interaction between melittin and lipid bilayers. J. Colloid Interface Sci. 311, 59–69 (2007).
Ulmschneider, J. P. & Ulmschneider, M. B. Melittin can permeabilize membranes via large transient pores. Nat. Commun. 15, 7281 (2024).
Sohlenkamp, C. & Geiger, O. Bacterial membrane lipids: diversity in structures and pathways. FEMS Microbiol. Rev. 40, 133–159 (2016).
Savini, F. et al. Binding of an antimicrobial peptide to bacterial cells: Interaction with different species, strains and cellular components. Biochimica et. biophysica acta Biomembranes 1862, 183291 (2020).
Gunasekera, S., Muhammad, T., Strömstedt, A. A., Rosengren, K. J. & Göransson, U. Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability. Front. Microbiol. 11, 168 (2020).
Juhaniewicz-Debinska, J. Melittin-Induced Structural Transformations in DMPG and DMPS Lipid Membranes: A Langmuir Monolayer and AFM Study. Molecules (Basel, Switzerland) 29, 6064 (2024).
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
Scheenstra, M. R. et al. Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action. Sci. Rep. 9, 4780 (2019).
Te Winkel, J. D., Gray, D. A., Seistrup, K. H., Hamoen, L. W. & Strahl, H. Analysis of Antimicrobial-Triggered Membrane Depolarization Using Voltage Sensitive Dyes. Front. Cell Dev. Biol. 4, 29 (2016).
Cantón, R. & Morosini, M.-I. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol. Rev. 35, 977–991 (2011).
Kowalska-Krochmal, B. & Dudek-Wicher, R. The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance. Pathogens (Basel, Switzerland) 10, 165 (2021).
O’Neill, A. J. & Chopra, I. Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques. Expert Opin. investigational drugs 13, 1045–1063 (2004).
Loffredo, M. R. et al. Inoculum effect of antimicrobial peptides. Proc. Natl. Acad. Sci. USA. 118, e2014364118 (2021).
Oliver, P. M. et al. Localization of anionic phospholipids in Escherichia coli cells. J. Bacteriol. 196, 3386–3398 (2014).
Pandidan, S. & Mechler, A. Nano-viscosimetry analysis of the membrane disrupting action of the bee venom peptide melittin. Sci. Rep. 9, 10841 (2019).
Wimley, W. C. How Does Melittin Permeabilize Membranes? Biophysical J. 114, 251–253 (2018).
Papo, N. & Shai, Y. Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides. Biochemistry 42, 458–466 (2003).
Ramírez-Montiel, F. et al. Plasma membrane damage repair is mediated by an acid sphingomyelinase in Entamoeba histolytica. PLoS Pathog. 15, e1008016 (2019).
Blazek, A. D., Paleo, B. J. & Weisleder, N. Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis. Physiol. (Bethesda, Md.) 30, 438–448 (2015).
Daussy, C. F. & Wodrich, H. “Repair Me if You Can”: Membrane Damage, Response, and Control from the Viral Perspective. Cells 9, 2042 (2020).
Lee, M.-T., Sun, T.-L., Hung, W.-C. & Huang, H. W. Process of inducing pores in membranes by melittin. Proc. Natl. Acad. Sci. USA 110, 14243–14248 (2013).
Kamiura, R., Matsuda, F. & Ichihashi, N. Survival of membrane-damaged Escherichia coli in a cytosol-mimicking solution. J. Biosci. Bioeng. 128, 558–563 (2019).
Sreepadmanabh, M. et al. Cell shape affects bacterial colony growth under physical confinement. Nat. Commun. 15, 9561 (2024).
Trinh, K. T. L. & Lee, N. Y. Recent Methods for the Viability Assessment of Bacterial Pathogens: Advances, Challenges, and Future Perspectives. Pathogens (Basel, Switzerland) 11, 1057 (2022).
Lempp, M., Lubrano, P., Bange, G. & Link, H. Metabolism of non-growing bacteria. Biol. Chem. 401, 1479–1485 (2020).
Zamaraeva, M. V. et al. Cells die with increased cytosolic ATP during apoptosis: a bioluminescence study with intracellular luciferase. Cell Death Differ. 12, 1390–1397 (2005).
Farha, M. A., Verschoor, C. P., Bowdish, D. & Brown, E. D. Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus. Chem. Biol. 20, 1168–1178 (2013).
Choi, H., Yang, Z. & Weisshaar, J. C. Oxidative stress induced in E. coli by the human antimicrobial peptide LL-37. PLoS Pathog. 13, e1006481 (2017).
Zhu, Y., Mohapatra, S. & Weisshaar, J. C. Rigidification of the Escherichia coli cytoplasm by the human antimicrobial peptide LL-37 revealed by superresolution fluorescence microscopy. Proc. Natl. Acad. Sci. USA 116, 1017–1026 (2019).
Sani, M.-A., Henriques, S. T., Weber, D. & Separovic, F. Bacteria May Cope Differently from Similar Membrane Damage Caused by the Australian Tree Frog Antimicrobial Peptide Maculatin 1.1. J. Biol. Chem. 290, 19853–19862 (2015).
Separovic, F., Hofferek, V., Duff, A. P., McConville, M. J. & Sani, M.-A. In-cell DNP NMR reveals multiple targeting effect of antimicrobial peptide. J. Struct. Biol.: X 6, 100074 (2022).
Nell, M. J. et al. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27, 649–660 (2006).
Malanovic, N. et al. S-adenosyl-L-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and triacylglycerol homeostasis in yeast: implications for homocysteine as a risk factor of atherosclerosis. J. Biol. Chem. 283, 23989–23999 (2008).
Zegarlińska, J., Piaścik, M., Sikorski, A. F. & Czogalla, A. Phosphatidic acid – a simple phospholipid with multiple faces. Acta biochimica Polonica 65, 163–171 (2018).
Kulig, W. et al. Complex Behavior of Phosphatidylcholine-Phosphatidic Acid Bilayers and Monolayers: Effect of Acyl Chain Unsaturation. Langmuir: ACS J. Surf. colloids 35, 5944–5956 (2019).
Eaton, J. M. et al. Lipin 2 binds phosphatidic acid by the electrostatic hydrogen bond switch mechanism independent of phosphorylation. J. Biol. Chem. 289, 18055–18066 (2014).
Bechinger, B. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state NMR spectroscopy. Biochimica et. biophysica acta. 1462, 157–183 (1999).
Batenburg, A. M. et al. Interaction of melittin with negatively charged phospholipids: consequences for lipid organization. FEBS Lett. 223, 148–154 (1987).
Wang, X. et al. Analyzing mechanisms of action of antimicrobial peptides on bacterial membranes requires multiple complimentary assays and different bacterial strains. Biochimica et. biophysica acta Biomembranes. 1865, 184160 (2023).
Agrawal, A., Rangarajan, N. & Weisshaar, J. C. Resistance of early stationary phase E. coli to membrane permeabilization by the antimicrobial peptide Cecropin A. Biochimica et. biophysica acta Biomembranes 1861, 182990 (2019).
Tan, B. K. et al. Discovery of a cardiolipin synthase utilizing phosphatidylethanolamine and phosphatidylglycerol as substrates. Proc. Natl. Acad. Sci. USA 109, 16504–16509 (2012).
Domadia, P. N., Bhunia, A., Ramamoorthy, A. & Bhattacharjya, S. Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization. J. Am. Chem. Soc. 132, 18417–18428 (2010).
Chitolie, M. S. & Toescu, E. C. High-throughput method for dynamic measurements of cellular viability using a BMG LABTECH microplate reader. The BMG LABTECH (2008).
Crowley, L. C. et al. Measuring Cell Death by Propidium Iodide Uptake and Flow Cytometry. Cold Spring Harb. protoc. 2016, https://doi.org/10.1101/pdb.prot087163 (2016).
Scheinpflug, K. et al. Antimicrobial peptide cWFW kills by combining lipid phase separation with autolysis. Sci. Rep. 7, 44332 (2017).